A high malignancy of gliomas with the IDH1 R132H and TP53 R248Q mutations is due to both substitutions, which is also determined by a high level of CS synthesis in gliomas, especially in high-grade astrocytoma and glioblastoma [41]. Here, TP53 is linked to central nervous system cancer.